Pirro V, Roth KD, Lin Y, Willency JA, Milligan PL, Wilson JM, Ruotolo G, Haupt A, Newgard CB, Duffin KL
Eur J Pharmacol 2022;914:174635.ArticlePubMed REFERENCES PubReader ePub Link Cite this Article Cite this Article Close Download Citation Close XML Download Figure Fig
Bottom line: Theyre concerned about what will happen when people many in far greater need than me cant pay for their medication
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies
Notably, patients on GLP-1 RAs exhibited a 195% higher risk of major depression, a 108% increased risk for anxiety, and a 106% elevated risk for suicidal behavior
Participants who received retatrutide also started at 2 mg and titrated up to their target dose